Cytomegalovirus (CMV) Antikörper

Produktnummer ABIN3026155

Produktdetails

Target: Cytomegalovirus (CMV)

Reaktivität: Cytomegalovirus (CMV)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: Immunofluorescence (IF), ELISA, Immunocytochemistry (ICC)

Aufreinigung: Protein G purified CMV antibody

Klon: CMV100

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise: The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the CMV antibody to be titered up or down for optimal performance.\. ELISA: order BSA-free CMV antibody format for coating,Immunocytochemistry (Acetone or paraformaldehyde fixed) 0.5-1 μg/mL for 30 min,IF: 0.5-1 μg/mL

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Konservierungsmittel: Azide free

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store the CMV antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).

Antigendetails

Target: Cytomegalovirus (CMV)

Andere Bezeichnung: CMV Cytomegalovirus (CMV Produkte)

Synonyme: CMVFR antikoerper, transmembrane anterior posterior transformation 1 antikoerper, TAPT1 antikoerper

Substanzklasse: Virus

Hintergrund: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.